Companies / Citius Pharmaceuticals, Inc.

Citius Pharmaceuticals, Inc.

NasdaqCIK 1506251CRANFORD, NJ

Financials · FY2013

Revenue$0
Net income$-39.74M
Total debt—
Cash$4.59M
Diluted EPS$-3.38
Shares outstanding27.5M

Ownership

27.5M shares outstanding · as of May 14, 2026
100.0%Public float
Ownership
Public float100.00%27,452,570

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 0

View all →
Insider% of sharesShares
No insiders recorded yet.

Institutional holders 0

HolderValue% of shares
No institutional holders on file.

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
No activity matches these filters.

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
CVI Investments, Inc.Passive13G/A———